Which aspirin dose best prevents preeclampsia? new trial aims to find out
NCT ID NCT07041385
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 23 times
Summary
This study tests whether a higher dose (150 mg) of daily aspirin is better than the standard dose (75 mg) at preventing preeclampsia, a dangerous pregnancy complication. The trial will enroll 340 high-risk pregnant women aged 18-30. Researchers will track who develops preeclampsia and whether the baby is born early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA (PE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shalamar Hospital
Lahore, Punjab Province, 54000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.